Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Mittler

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Advances in Virus Research|August 24, 2019
Hantavirus entry: Perspectives and recent advancesEva Mittler, Maria Eugenia Dieterle, Lara M Kleinfelter, et al.
Viruses|April 12, 2014
Analysis of determinants in filovirus glycoproteins required for tetherin antagonismKerstin Gnirß, Marie Fiedler, Annika Krämer-Kühl, et al.
Journal of Virology|January 15, 2005
VP40 octamers are essential for Ebola virus replicationThomas Hoenen, Viktor Volchkov, Larissa Kolesnikova, et al.
Mbio|February 17, 2021
A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane FusionJ Maximilian Fels, Robert H Bortz, Tanwee Alkutkar, et al.
ACS Infectious Diseases|October 13, 2025
Hantavirus Gn<sup>H</sup> Nanoparticle Immunogen Elicits a Cross-Neutralizing Antibody Response in MiceKevin E Ramos, Margarette C Mariano, Eva Mittler, et al.
Immunology Letters|September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibodyDaniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Elife|July 7, 2021
Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cellsMaria Eugenia Dieterle, Carles Solà-Riera, Chunyan Ye, et al.
Ebiomedicine|January 9, 2026
Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infectionJordan J Clark, Stefan Hatzl, Kirill Vasilev, et al.
Journal of Virology|July 3, 2020
A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its InhibitionRobert H Bortz, Anthony C Wong, Michael G Grodus, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Advances in Virus Research|August 24, 2019
Hantavirus entry: Perspectives and recent advancesEva Mittler, Maria Eugenia Dieterle, Lara M Kleinfelter, et al.
Viruses|April 12, 2014
Analysis of determinants in filovirus glycoproteins required for tetherin antagonismKerstin Gnirß, Marie Fiedler, Annika Krämer-Kühl, et al.
Journal of Virology|January 15, 2005
VP40 octamers are essential for Ebola virus replicationThomas Hoenen, Viktor Volchkov, Larissa Kolesnikova, et al.
Mbio|February 17, 2021
A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane FusionJ Maximilian Fels, Robert H Bortz, Tanwee Alkutkar, et al.
ACS Infectious Diseases|October 13, 2025
Hantavirus Gn<sup>H</sup> Nanoparticle Immunogen Elicits a Cross-Neutralizing Antibody Response in MiceKevin E Ramos, Margarette C Mariano, Eva Mittler, et al.
Immunology Letters|September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibodyDaniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Elife|July 7, 2021
Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cellsMaria Eugenia Dieterle, Carles Solà-Riera, Chunyan Ye, et al.
Ebiomedicine|January 9, 2026
Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infectionJordan J Clark, Stefan Hatzl, Kirill Vasilev, et al.
Journal of Virology|July 3, 2020
A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its InhibitionRobert H Bortz, Anthony C Wong, Michael G Grodus, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Pageof 4